StockNews.AI
ILMN
StockNews.AI
131 days

Illumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025

1. Illumina will announce Q1 2025 results on May 8, 2025. 2. CEO Jacob Thaysen and CFO Ankur Dhingra will lead an analyst call. 3. The call will provide insights into financial and operational performance. 4. Investors can access results via the company website. 5. Illumina focuses on revolutionizing genomics and improving human health.

4m saved
Insight
Article

FAQ

Why Bullish?

Earnings reports can drive investor optimism if results exceed expectations, as seen in prior earnings where positive news led to stock rallies.

How important is it?

The earnings results will provide key insights that could shape market sentiment and strategy for investors in ILMN.

Why Short Term?

The announcement of Q1 results will have a direct short-term effect, impacting market perception and stock movement immediately post-release.

Related Companies

AMGNGILDVRTX
, /PRNewswire/ -- Illumina, Inc. (NASDAQ:ILMN) announced today that it will issue results for the first quarter 2025 following the close of market on Thursday, May 8, 2025.  On the same day, at 1:30 pm Pacific Time (4:30 pm Eastern Time) Jacob Thaysen, PhD, Chief Executive Officer, and Ankur Dhingra, Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties to discuss financial and operating results.  Conference Call Details The conference call will begin at 1:30 pm Pacific Time (4:30 pm Eastern Time) on Thursday, May 8, 2025. Interested parties may access the live webcast via the Investor Info section of Illumina's website or directly through the following link - https://illumina-earnings-call-q1-2025.open-exchange.net/registration. To ensure timely connection, please join at least ten minutes before the scheduled start of the call. A replay of the conference call will be posted on Illumina's website after the event and will be available for at least 30 days following. About Illumina Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and connect with us on X (Twitter), Facebook, LinkedIn, Instagram, TikTok, and YouTube. Investors:Brian Blanchett+1.858.291.6421[email protected] Media:Bonny Fowler+1.740.641.5579[email protected] SOURCE Illumina, Inc. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News